.Ideaya Biosciences is betting $400 thousand in biobucks that a bispecific antibody-drug conjugate (...
.Our experts already understand that Takeda is wishing to discover a path to the FDA for epilepsy me...
.Immunology biotech VBI Injections is diverting hazardously near to the climax, with plans to file f...
.It's hard to muscular tissue in on an area as affordable as immunology, but Celldex Therapeutics st...
.Boehringer Ingelheim is actually offering up to $1.3 billion for Nerio Therapies as well as a precl...
.Ventyx Biosciences' Crohn's ailment medication did certainly not help clients obtain remission in a...
.Cognition Therapies' stage 2 luster trial has taken several of the appeal off the Alzheimer's disea...
.Bristol Myers Squibb has had a whiplash change of mind on its BCMA bispecific T-cell engager, stopp...
.Charles Baum, M.D., Ph.D., who looked after Mirati Rehabs' $ 5.8 billion sale to Bristol Myers Squi...
.After reaching out to greater than 200 companies to partner a Tourette syndrome therapy that showed...